BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

704 related articles for article (PubMed ID: 18082667)

  • 1. Second-trimester pregnancy termination with 600-microg vs. 400-microg vaginal misoprostol and systematic curettage postexpulsion: a randomized trial.
    Carbonell JL; Torres MA; Reyes R; Ortega L; García-Gallego F; Sánchez C
    Contraception; 2008 Jan; 77(1):50-5. PubMed ID: 18082667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First-trimester pregnancy termination with 800 microg of vaginal misoprostol every 12 h.
    Salakos N; Kountouris A; Botsis D; Rizos D; Gregoriou O; Detsis G; Creatsas G
    Eur J Contracept Reprod Health Care; 2005 Dec; 10(4):249-54. PubMed ID: 16448952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two regimens of vaginal misoprostol in second trimester termination of pregnancy: a prospective randomised trial.
    Bhattacharyya SK; Mukherji J; Kamilya GS; Ray S; Hazra A
    Acta Obstet Gynecol Scand; 2006; 85(12):1458-62. PubMed ID: 17260222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of two regimens of misoprostol for second trimester medical termination of pregnancy: a randomized trial.
    Chaudhuri S; Banerjee PK; Mundle M; Mitra SN
    Trop Doct; 2010 Jul; 40(3):144-8. PubMed ID: 20555044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of vaginal and sublingual misoprostol for second trimester abortion: randomized controlled equivalence trial.
    von Hertzen H; Piaggio G; Wojdyla D; Nguyen TM; Marions L; Okoev G; Khomassuridze A; Kereszturi A; Mittal S; Nair R; Daver R; Pretnar-Darovec A; Dickson K; Nguyen DH; Nguyen HB; Hoang TD; Peregoudov A;
    Hum Reprod; 2009 Jan; 24(1):106-12. PubMed ID: 18794161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized trial of buccal versus vaginal misoprostol for induction of second trimester abortion.
    Ellis SC; Kapp N; Vragpvoc O; Borgata L
    Contraception; 2010 May; 81(5):441-5. PubMed ID: 20399952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sublingual misoprostol 100 microgram versus 200 microgram for second trimester abortion: a randomised trial.
    Caliskan E; Doger E; Cakiroglu Y; Corakci A; Yucesoy I
    Eur J Contracept Reprod Health Care; 2009 Feb; 14(1):55-60. PubMed ID: 19241302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomised controlled trial of 6 and 12 hourly administration of vaginal misoprostol for second trimester pregnancy termination.
    Herabutya Y; Chanrachakul B; Punyavachira P
    BJOG; 2005 Sep; 112(9):1297-301. PubMed ID: 16101611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A viable alternative to surgical vacuum aspiration: repeated doses of intravaginal misoprostol over 9 hours for medical termination of pregnancies up to eight weeks.
    Singh K; Fong YF; Dong F
    BJOG; 2003 Feb; 110(2):175-80. PubMed ID: 12618162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Misoprostol moistened with acetic acid or saline for second trimester pregnancy termination: a randomized prospective double-blind trial.
    Yilmaz B; Kelekci S; Ertas IE; Kahyaoglu S; Ozel M; Sut N; Danisman N
    Hum Reprod; 2005 Nov; 20(11):3067-71. PubMed ID: 16037107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomised controlled trial comparing the efficacy of same-day administration of mifepristone and misoprostol for termination of pregnancy with the standard 36 to 48 hour protocol.
    Guest J; Chien PF; Thomson MA; Kosseim ML
    BJOG; 2007 Feb; 114(2):207-15. PubMed ID: 17305893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaginal misoprostol 800 microg every 12 h for second-trimester abortion.
    Carbonell JL; Rodríguez J; Delgado E; Sánchez C; Vargas F; Valera L; Marí J; Valero F; Salvador I; Llorente M
    Contraception; 2004 Jul; 70(1):55-60. PubMed ID: 15208053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaginal vs. sublingual misoprostol with mifepristone for cervical priming in second-trimester abortion by dilation and evacuation: a randomized clinical trial.
    Carbonell JL; Gallego FG; Llorente MP; Bermudez SB; Sala ES; González LV; Texido CS
    Contraception; 2007 Mar; 75(3):230-7. PubMed ID: 17303495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective randomised comparison of sublingual and vaginal misoprostol in second trimester termination of pregnancy.
    Tang OS; Lau WN; Chan CC; Ho PC
    BJOG; 2004 Sep; 111(9):1001-5. PubMed ID: 15327617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Misoprostol is as effective as gemeprost in termination of second trimester pregnancy when combined with mifepristone: a randomised comparative trial.
    Ho PC; Chan YF; Lau W
    Contraception; 1996 May; 53(5):281-3. PubMed ID: 8724617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomised controlled trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion up to 13 weeks of gestation.
    Hamoda H; Ashok PW; Flett GM; Templeton A
    BJOG; 2005 Aug; 112(8):1102-8. PubMed ID: 16045525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized comparison of dry tablet insertion versus gel form of vaginal misoprostol for second trimester pregnancy termination.
    Pongsatha S; Tongsong T
    J Obstet Gynaecol Res; 2008 Apr; 34(2):199-203. PubMed ID: 18412782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Termination of pregnancy in patients with previous cesarean section.
    Mazouni C; Provensal M; Porcu G; Guidicelli B; Heckenroth H; Gamerre M; Bretelle F
    Contraception; 2006 Mar; 73(3):244-8. PubMed ID: 16472563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Misoprostol for abortion at 9-12 weeks' gestation in adolescents.
    Carbonell JL; Velazco A; Varela L; Tanda R; Sánchez C; Barambio S; Chami S; Valero F; Aragón S; Marí J
    Eur J Contracept Reprod Health Care; 2001 Mar; 6(1):39-45. PubMed ID: 11334475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of second trimester abortion (12-20 weeks) with mifepristone and misoprostol: a review of 386 consecutive cases.
    Goh SE; Thong KJ
    Contraception; 2006 May; 73(5):516-9. PubMed ID: 16627037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.